- Home
- About
- Products
- E1 Activating
- E2 Conjugating
- E3 Ligase
- Deconjugating
- Proteasome
- Ubiquitin
- All
- Ubiquitin and Ubiquitin Derivatives
- Ubiquitin Chains
- DUB-Resistant, Non-Hydrolyzable Chains
- NH Isopeptide-linked chains
- DCA Linked Chains
- K6-linked Chains (DCA)
- Agarose Bound K6-linked Chains (DCA)
- K11-linked Chains (DCA)
- Agarose Bound K11-linked Chains (DCA)
- K29-linked Chains (DCA)
- Agarose Bound K29-linked Chains (DCA)
- K33-linked Chains (DCA)
- Agarose Bound K33-linked Chains (DCA)
- K48-linked Chains (DCA)
- Agarose Bound K48-linked Chains (DCA)
- K63-linked Chains (DCA)
- Agarose Bound K63-linked Chains (DCA)
- K76-linked Chains (DCA)
- Agarose Bound K76-linked Chains (DCA)
- Ubiquitin Mutants
- Labeled Ubiquitin Proteins
- Antibodies, ELISAs and Kits
- SUMO
- NEDD8
- ISG15
- UFM1
- URM1
- Autophagy
- FAT10
- Inhibitors
- Antibodies
- Kits
- Buffers, Solutions, Standards
- Substrate Proteins
- Affinity Matrices / Proteins
- Fractions
- FUBI
- References
- Orders
- Contact
Material Data Sheet
Thalidomide - E3 Ligase, CRBN
Price: $65.00
Thalidomide - E3 Ligase, CRBN
Price:
$65
Quantity:
100 mg
Data Sheet:
Teratogen, sedative-hypnotic with inherent anti-inflammatory properties. A thalidomide-binding protein, cereblon (CRBN), forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks. Thalidomide initiates its teratogenic effects by binding to CRBN and inhibiting the associated ubiquitin ligase activity.
Product Information
FW:
258.23
Purity:
>99%
Solubility:
Soluble to 25 mM in DMSO Use & Storage
Use:
Add from DMSO stock directly to in vitro or in vivo assays at desired concentration. Pre-incubation with compound prior to assay is recommended for maximal effect.
Storage:
Store stock solution at -20°C. Avoid multiple freeze/thaw cycles.
Literature
References:
Merck Index 12: 9390
Sampaio, et al (1991) J.Exp.Med. 173: 699
Makonkawkeyoon, et al (1993) Proc. Natl. Acad. Sci. USA. 90: 5974
Kanbayashi, et al (1996) Neuroreport 7:1881
Boireau, et al (1997) Neurosci.Lett. 234:123
Zhang, et al (2008) J.Exp.Clin.Cancer Res. 4: 27






